Seeking exceptional
RLT Institution Account Executive - Oncology
Over the last decade, Curium has positioned itself as a global leader in nuclear medicine. Its vertically integrated, global supply chain reliably delivers diagnostic and therapeutic radiopharmaceuticals to more than 14 million patients in over 70 countries across 6 continents every year. Curium boasts a broad portfolio of diagnostic radiopharmaceuticals and has an exciting, late-stage pipeline of Radioligand Therapies (RLTs) targeting neuroendocrine and prostate cancers, the two largest indications in nuclear medicine. Now is the time to join Curium to help us build on to our legacy – be a part of the commercial team that brings our radioligand therapies to more patients and helps shape the future of care in neuroendocrine and prostate cancers.
"We believe that 80% of cancers can be attacked using radioligand therapy."
Mike Patterson
CEO North America
"Cancer doesn’t care who it attacks. Our technology can find and kill it, even when it has spread to the smallest corners of the body."
Renaud Dehareng
Curium Group CEO
"It’s quite meaningful to work with a company that is impacting patient lives in a positive way and is contributing to the benefit of other humans."
Michael Gruen
Senior Director People
Employee Voices
Living our purpose
Yvette Whitlock
Director Customer Service
Employee Voices
Living our purpose
Michael Gruen
Senior Director Human Resources
Application process
Working at Curium means working with the best to take on fresh challenges in a collaborative environment. It means focusing on teamwork with safety in mind. It means making a difference every day to the patients we serve. We’re glad you are interested in our amazing organization! Follow our simple application process to begin your journey towards a career with Curium.